Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatric disorders with ALPHA5-containing GABAA receptor agonists

Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatric disorders with ALPHA5-containing GABAA receptor agonists

US Patent 10906909 · Granted Feb 2, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatr2024
Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatr2024
Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatr2024
Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatr2024
Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatr2024
Substituted benzo[f]imidazo[1,5-a][1,4]diazepines as GABA(a) receptor modulators2024
Substituted benzo[f]imidazo[1,5-a][1,4]diazepines as GABA(a) receptor modulators2024
Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatr2023
Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatr2023
Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatr2023
Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatr2023
Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatr2023